XTANT MEDICAL HOLDINGS, INC. Revenue from Contract with Customer, Including Assessed Tax
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Revenue from Contract with Customer, Including Assessed Tax of $64.52 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-05.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2020-03-05
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2019-12-31 was $16.94M, a 6.87% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2019-09-30 was $15.69M, a 8.45% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2019-06-30 was $15.20M, a 18.53% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, including assessed tax for the quarter ending 2019-03-31 was $16.69M, a 6.42% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, including assessed tax for fiscal 2019 was $64.52M, a 10.16% decline from fiscal 2018.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, including assessed tax for fiscal 2018 was $71.81M, a 12.97% decline from fiscal 2017.
- XTANT MEDICAL HOLDINGS, INC. revenue from contract with customer, including assessed tax for fiscal 2017 was $82.51M.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month | Revenue from Contract with Customer, Including Assessed Tax 9 month | Revenue from Contract with Customer, Including Assessed Tax 12 month |
|---|---|---|---|---|
| 2019-12-31 | $16.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $32.63M derived: sum of 2 quarters · filed 2020-03-05 | $47.83M derived: sum of 3 quarters · filed 2020-03-05 | $64.52M 10-K · filed 2020-03-05 |
| 2019-09-30 | $15.69M 10-Q · filed 2019-11-07 | $30.89M derived: sum of 2 quarters · filed 2019-11-07 | $47.57M 10-Q · filed 2019-11-07 | $65.77M derived: sum of 4 quarters · filed 2020-03-05 |
| 2019-06-30 | $15.20M 10-Q · filed 2019-08-08 | $31.88M 10-Q · filed 2019-08-08 | $50.08M derived: sum of 3 quarters · filed 2020-03-05 | $67.21M derived: sum of 4 quarters · filed 2020-03-05 |
| 2019-03-31 | $16.69M 10-Q · filed 2019-05-15 | $34.88M derived: sum of 2 quarters · filed 2020-03-05 | $52.02M derived: sum of 3 quarters · filed 2020-03-05 | $70.67M derived: sum of 4 quarters · filed 2020-03-05 |
| 2018-12-31 | $18.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $35.33M derived: sum of 2 quarters · filed 2020-03-05 | $53.98M derived: sum of 3 quarters · filed 2020-03-05 | $71.81M 10-K · filed 2020-03-05 |
| 2018-09-30 | $17.14M 10-Q · filed 2019-11-07 | $35.79M derived: sum of 2 quarters · filed 2019-11-07 | $53.62M 10-Q · filed 2019-11-07 | $73.15M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $18.65M 10-Q · filed 2019-08-08 | $36.48M 10-Q · filed 2019-08-08 | $56.01M derived: sum of 3 quarters · filed 2019-08-08 | $75.63M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $17.83M 10-Q · filed 2019-05-15 | $37.36M derived: sum of 2 quarters · filed 2019-05-15 | $56.98M derived: sum of 3 quarters · filed 2019-05-15 | $78.35M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $19.53M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $39.15M derived: sum of 2 quarters · filed 2019-04-01 | $60.52M derived: sum of 3 quarters · filed 2019-04-01 | $82.51M 10-K · filed 2019-04-01 |
| 2017-09-30 | $19.62M 10-Q · filed 2018-11-14 | $40.99M derived: sum of 2 quarters · filed 2018-11-14 | $62.99M 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $21.37M 10-Q · filed 2018-08-08 | $43.37M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |